Shopping Cart
- Remove All
- Your shopping cart is currently empty
Borofalan (also known as SPM 011) is an adjuvant compound used in boron neutron capture therapy (BNCT) for cancer treatment. BNCT leverages the high neutron capture cross-section of boron-containing compounds (10 B) and facilitates the 10 B(n,α) 7 Li neutron capture and nuclear fission reaction. With the use of borofalan (10B)-containing C-BENS, BNCT has demonstrated effective therapeutic potential in patients with R-SCC or R/LA-nSCC of the head and neck. Note: We offer the non-labeled version of Borofalan.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | Borofalan (also known as SPM 011) is an adjuvant compound used in boron neutron capture therapy (BNCT) for cancer treatment. BNCT leverages the high neutron capture cross-section of boron-containing compounds (10 B) and facilitates the 10 B(n,α) 7 Li neutron capture and nuclear fission reaction. With the use of borofalan (10B)-containing C-BENS, BNCT has demonstrated effective therapeutic potential in patients with R-SCC or R/LA-nSCC of the head and neck. Note: We offer the non-labeled version of Borofalan. |
Alias | L-Phenylalanine, 4-borono-, hydrochloride, Boronophenylalanine hydrochloride, (S)-2-Amino-3-(4-boronophenyl)propanoic acid hydrochloride |
Molecular Weight | 245.47 |
Formula | C9H13BClNO4 |
Cas No. | 76410-59-8 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.